Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ceftizoxime and other third-generation cephalosporins: structure-activity relationships.

Literature DB >> 6295993

Ceftizoxime and other third-generation cephalosporins: structure-activity relationships.

G L Dunn.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1982 PMID： 6295993 DOI： 10.1093/jac/10.suppl_c.1

Source DB: PubMed Journal: J Antimicrob Chemother ISSN： 0305-7453 Impact factor: 5.790

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

Review 1. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.

Authors: George G Zhanel; Alyssa R Golden; Sheryl Zelenitsky; Karyn Wiebe; Courtney K Lawrence; Heather J Adam; Temilolu Idowu; Ronald Domalaon; Frank Schweizer; Michael A Zhanel; Philippe R S Lagacé-Wiens; Andrew J Walkty; Ayman Noreddin; Joseph P Lynch Iii; James A Karlowsky
Journal: Drugs Date: 2019-02 Impact factor: 9.546

2. Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis.

Authors: D F Sahm; C N Baker; R N Jones; C Thornsberry
Journal: J Clin Microbiol Date: 1984-09 Impact factor: 5.948

3. Third generation cephalosporins.

Authors: I M Gould; R Wise
Journal: Br Med J (Clin Res Ed) Date: 1985-03-23

Review 4. Antibiotics for emerging pathogens.

Authors: Michael A Fischbach; Christopher T Walsh
Journal: Science Date: 2009-08-28 Impact factor: 47.728

Review 5. Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

Authors: George G Zhanel; Christopher D Lawson; Heather Adam; Frank Schweizer; Sheryl Zelenitsky; Philippe R S Lagacé-Wiens; Andrew Denisuik; Ethan Rubinstein; Alfred S Gin; Daryl J Hoban; Joseph P Lynch; James A Karlowsky
Journal: Drugs Date: 2013-02 Impact factor: 9.546

Review 10. Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections.

Authors: Philippe Lagacé-Wiens; Andrew Walkty; James A Karlowsky
Journal: Core Evid Date: 2014-01-24

Ceftizoxime and other third-generation cephalosporins: structure-activity relationships.

Review 1. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.

2. Influence of growth medium on the in vitro activities of second- and third-generation cephalosporins against Streptococcus faecalis.

3. Third generation cephalosporins.

Review 4. Antibiotics for emerging pathogens.

Review 5. Ceftazidime-avibactam: a novel cephalosporin/β-lactamase inhibitor combination.

6. Nephrotoxic potential of first-, second-, and third-generation cephalosporins.

Review 7. Clinical pharmacokinetics of the third generation cephalosporins.

Review 8. Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Review 9. Ceftazidime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Review 10. Ceftazidime-avibactam: an evidence-based review of its pharmacology and potential use in the treatment of Gram-negative bacterial infections.